Preterm Premature Rupture of the Membranes

Preterm Birth: Prevention and Management

Volumn , Issue , 2010, Pages 217-231

  Mercer, Brian M ^a,b  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b METROHEALTH MEDICAL CENTER   (United States)

Author keywords

PPROM; Pregnancy; Premature rupture of the membranes; Prematurity; Preterm birth; PROM

Indexed keywords

EID: 80053442106     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781444317619.ch19     Document Type: Chapter

References (58)

1. Ventura SJ, Martin JA, Taffel SM, Mathews TJ, Clarke SC. Advance report of final natality statistics, 1993. Monthly Vital Statistics Report from the Centers For Disease Control and Prevention 1995; 44 (3S): 1-88.
2. Ananth CV, Joseph KS, Oyelese Y, Demissie K, Vintzileos AM. Trends in preterm birth and perinatal mortality among singletons: United States, 1989 through 2000. Obstet Gynecol 2005; 105:1084-91.
3. Mercer BM, Arheart KL. Antimicrobial therapy in expectant management of preterm premature rupture of the membranes. Lancet 1995; 346:1271-9.
4. Waters TP, Mercer BM. The management of preterm premature rupture of the membranes near the limit of fetal viability. Am J Obstet Gynecol 2009; 201:230-40.
5. Muris C, Girard B, Creveuil C, et al. Management of premature rupture of membranes before 25 weeks. Eur J Obstet Gynecol Reprod Biol 2007; 131:163-8.
6. Mercer BM. Preterm premature rupture of the membranes. Obstet Gynecol 2003; 358:178-93.
7. Tyson JE, Parikh NA, Langer J, Green C, Higgins RD. Intensive care for extreme prematurity: moving beyond gestational age. N Engl J Med 2008; 358:1672-81.
8. Locatelli A, Ghidini A, Paterlini G, et al. Gestational age at preterm premature rupture of membranes: a risk factor for neonatal white matter damage. Am J Obstet Gynecol 2005; 193:947-51.
9. Wu YW, Colford JM Jr. Chorioamnionitis as a risk factor for cerebral palsy: a meta-analysis. JAMA 2000; 284:1417-24.
10. Yoon BH, Jun JK, Romero R, et al. Amniotic fluid inflammatory cytokines (interleukin-6, interleukin-1 beta, and tumor necrosis factor-alpha), neonatal brain white matter lesions, and cerebral palsy. Am J Obstet Gynecol 1997; 177:19-26.
11. Yoon BH, Romero R, Yang SH, et al. Interleukin-6 concentrations in umbilical cord plasma are elevated in neonates with white matter lesions associated with periventricular leukomalacia. Am J Obstet Gynecol 1996; 174:1433-40.
12. Alexander JM, Mercer BM, Miodovnik M, et al. The impact of digital cervical examination on expectantly managed preterm rupture of membranes. Am J Obstet Gynecol 2000; 183:1003-7.
13. Lewis DF, Major CA, Towers CV, et al. Effects of digital vaginal examinations on latency period in preterm premature rupture of membranes. Obstet Gynecol 1992; 80:630-4.
14. Imseis HM, Trout WC, Gabbe SG. The microbiologic effect of digital cervical examination. Am J Obstet Gynecol 1999; 180:578-80.
15. Reece EA, Chervenak FA, Moya FR, Hobbins JC. Amniotic fluid arborization: effect of blood, meconium, and pH alterations. Obstet Gynecol 1984; 64:248-50.
16. Rosemond RL, Lombardi SJ, Boehm FH. Ferning of amniotic fluid contaminated with blood. Obstet Gynecol 1990; 75:338-40.
17. Lee SE, Park JS, Norwitz ER, Kim KW, Park HS, Jun JK. Measurement of placental alpha-microglobulin-1 in cervicovaginal discharge to diagnose rupture of membranes. Obstet Gynecol 2007; 109:634-40.
18. Lockwood CJ, Wein R, Chien D, et al. Fetal membrane rupture is associated with the presence of insulin-like growth factor-binding protein-1 in vaginal secretions. Am J Obstet Gynecol 1994; 171:146-50.
19. Gaucherand P, Guibaud S, Awada A, Rudigoz RC. Comparative study of three amniotic fluid markers in premature rupture of membranes: fetal fibronectin, alpha-fetoprotein, diamino-oxydase. Acta Obstet Gynecol Scand 1995; 74:118-21.
20. Lee SM, Lee J, Seong HS, et al. The clinical significance of a positive Amnisure test in women with term labor with intact membranes. J Matern Fetal Neonatal Med 2009; 22:305-10.
21. Prevention of early-onset group B streptococcal disease in newborns. ACOG Committee Opinion No. 279. American College of Obstetricians and Gynecologists. Obstet Gynecol 2002; 100:1405-12.
22. Carlan SJ, O'Brien WF, Parsons MT, Lense JJ. Preterm premature rupture of membranes: a randomized study of home vs hospital management. Obstet Gynecol 1993; 81:61-4.
23. Laudy JA, Tibboel D, Robben SG, et al. Prenatal prediction of pulmonary hypoplasia: clinical, biometric, and Doppler velocity correlates. Pediatrics 2002; 109:250-8.
24. Rizzo G, Capponi A, Angelini E, Mazzoleni A, Romanini C. Blood flow velocity waveforms from fetal peripheral pulmonary arteries in pregnancies with preterm premature rupture of the membranes: relationship with pulmonary hypoplasia. Ultrasound Obstet Gynecol 2000; 15:98-103.
25. Sciscione AC, Manley JS, Pollock M, et al. Intracervical fibrin sealants: a potential treatment for early preterm premature rupture of the membranes. Am J Obstet Gynecol 2001; 184:368-73.
26. Quintero RA, Morales WJ, Bornick PW, Allen M, Garabelis N. Surgical treatment of spontaneous rupture of membranes: the amniograft-first experience. Am J Obstet Gynecol 2002; 186:155-7.
27. O'Brien JM, Barton JR, Milligan DA. An aggressive interventional protocol for early midtrimester premature rupture of the membranes using gelatin sponge for cervical plugging. Am J Obstet Gynecol 2002; 187:1143-6.
28. Lewis DF, Adair CD, Weeks JW, Barrilleaux PS, Edwards MS, Garite TJ. A randomized clinical trial of daily nonstress testing versus biophysical profile in the management of preterm premature rupture of membranes. Am J Obstet Gynecol 1999; 181:1495-9.
29. Roberts D, Dalziel SR. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev 2006, Issue 3. Art. No.: CD004454. DOI:10.1002/14651858.CD004454.pub2.
30. Kenyon S, Boulvain M, Neilson JP. Antibiotics for preterm rupture of membranes. Cochrane Database Syst Rev 2003, Issue 2. Art. No.: CD001058. DOI: 10.1002/14651858.CD001058
31. Mercer BM, Miodovnik M, Thurnau G et al. Antibiotic therapy for reduction of infant morbidity after preterm premature rupture of the membranes. A randomized controlled trial. JAMA 1997; 278:989-95.
32. Kenyon SL, Taylor DJ, Tarnow-Mordi W; Oracle Collaborative Group. Broad spectrum antibiotics for preterm, prelabor rupture of fetal membranes: the ORACLE I Randomized trial. Lancet 2001; 357:979-88.
33. Kenyon S, Pike K, Jones DR et al. Childhood outcomes after prescription of antibiotics to pregnant women with preterm rupture of the membranes: 7-year follow-up of the ORACLE I trial. Lancet 2008; 372:1310-8.
34. Fortunato SJ, Bottom BW, Don RE, Welt SI, Swan KS. Study state cord and amniotic fluid Ceftizoxime levels continuously surpass maternal levels. Am J Obstet Gynecol 1988; 159:570-3.
35. De Leeuw JW, Roumen FJME, Bouckaert PXJM, Cremers HMHG, Vree TB. Achievement of therapeutic concentrations of Cephuroxime in early preterm gestations with premature rupture of the membranes. Obstet Gynecol 1993; 81:255-60.
36. Philpson A. Pharmacokinetics of antibiotics in pregnancy and labour. Clin Pharmacokinet 1979; 4:297-307.
37. Bloom SL, Cox SM, Bawdon RE, Gilstrap LC. Ampicillin for neonatal group B streptococcal prophylaxis: how rapidly can bactericidal concentrations be achieved? Am J Obstet Gynecol 1996; 175:974-6.
38. Doyle LW, Crowther CA, Middleton P, Marret S, Rouse D. Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus. Cochrane Database Syst Rev 2009, Issue 1. Art. No.: CD004661. DOI:10.1002/14651858.CD004661. pub3.
39. Rouse DJ, Hirtz DG, Thom E et al. A randomized, controlled trial of magnesium sulfate for the prevention of cerebral palsy. N Engl J Med 2008; 359:895-905.
40. Naef RW 3rd, Allbert JR, Ross EL et al. Premature rupture of membranes at 34 to 37 weeks 'gestation: aggressive versus conservative management. Am J Obstet Gynecol 1998; 178:126-30.
41. Mercer BM, Crocker L, Boe N, Sibai B. Induction vs expectant management in PROM with mature amniotic fluid at 32-36 weeks: a randomized trial. Am J Obstet Gynecol 1993; 82:775-82.
42. Mercer BM, Crocker LG, Pierce WF, Sibai BM. Clinical characteristics and outcome of twin gestation complicated by preterm premature rupture of the membranes. Am J Obstet Gynecol 1993; 168:1467-73.
43. Trentacoste SV, Jean-Pierre C, Baergen R, Chasen ST. Outcomes of preterm premature rupture of membranes in twin pregnancies. J Matern Fetal Neonatal Med 2008; 21:555-7.
44. Hsieh YY, Chang CC, Tsai HD et al. Twin vs singleton pregnancy. Clinical characteristics and latency periods in preterm premature rupture of membranes. J Reprod Med 1999; 44:616-20.
45. Bianco AT, Stone J, Lapinski R, Lockwood C, Lynch L, Berkowitz RL. The clinical outcome of preterm premature rupture of membranes in twin versus singleton pregnancies. Am J Perinatol 1996; 13:135-8.
46. Borenstein R, Shoham Z. Premature rupture of the membranes in a single twin gestational sac: a case report. J Reprod Med 1990; 35:270.
47. Amstey MS. Management of pregnancy complicated by genital herpes virus infection. Obstet Gynecol 1971; 37:515-20.
48. Nahmias AJ, Josey WE, Naib ZM, Freeman MG, Fernandez RJ, Wheeler JH. Perinatal risk associated with maternal genital herpes simplex virus infection. Am J Obstet Gynecol 1971; 110:825-37.
49. Major CA, Towers CV, Lewis DF, Garite TJ. Expectant management of preterm premature rupture of membranes complicated by active recurrent genital herpes. Am J Obstet Gynecol 2003; 188:1551-5.
50. Ludmir J, Bader T, Chen L, Lindenbaum C, Wong G. Poor perinatal outcome associated with retained cerclage in patients with premature rupture of membranes. Obstet Gynecol 1994; 84:823-6.
51. Jenkins TM, Berghella V, Shlossman PA et al. Timing of cerclage removal after preterm premature rupture of membranes: maternal and neonatal outcomes. Am J Obstet Gynecol 2000; 183:847-52.
52. McElrath TF, Norwitz ER, Lieberman ES, Heffner LJ. Perinatal outcome after preterm premature rupture of membranes with in situ cervical cerclage. Am J Obstet Gynecol 2002; 187:1147-52.
53. Mercer BM, Goldenberg RL, Meis PJ, et al. The Preterm Prediction Study: prediction of preterm premature rupture of the membranes through clinical findings and ancillary testing. Am J Obstet Gynecol 2000; 183:738-45.
54. Meis PJ, Klebanoff M, Thom E et al. Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate. N Engl J Med 2003; 348:2379-85.
55. da Fonseca EB, Bittar RE, Carvalho MH, Zugaib M. Prophylactic administration of progesterone by vaginal suppository to reduce the incidence of spontaneous preterm birth in women at increased risk: a randomized placebo-controlled double-blind study. Am J Obstet Gynecol 2003; 188:419-24.
56. O'Brien JM, Adair CD, Lewis DF et al. Progesterone vaginal gel for the reduction of recurrent preterm birth: primary results from a randomized, double-blind, placebo-controlled trial. Ultrasound Obstet Gynecol 2007; 30:687-96.
57. Casanueva E, Ripoll C, Tolentino M et al. Vitamin C supplementation to prevent premature rupture of the chorioamniotic membranes: a randomized trial. Am J Clin Nutr 2005; 81:859-63.
58. Spinnato JA 2nd, Freire S, Pinto e Silva JL et al. Antioxidant supplementation and premature rupture of the membranes: a planned secondary analysis. Am J Obstet Gynecol 2008; 199:433.e 1-8.